KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Non-Current Debt (2016 - 2022)

Historic Non-Current Debt for Medpace Holdings (MEDP) over the last 6 years, with Q2 2022 value amounting to $249.7 million.

  • Medpace Holdings' Non-Current Debt changed N/A to $249.7 million in Q2 2022 from the same period last year, while for Jun 2022 it was $249.7 million, marking a year-over-year change of. This contributed to the annual value of $79.7 million for FY2018, which is 6113.28% down from last year.
  • Per Medpace Holdings' latest filing, its Non-Current Debt stood at $249.7 million for Q2 2022.
  • In the past 5 years, Medpace Holdings' Non-Current Debt ranged from a high of $249.7 million in Q2 2022 and a low of $55.8 million during Q1 2019
  • Over the past 3 years, Medpace Holdings' median Non-Current Debt value was $130.4 million (recorded in 2018), while the average stood at $137.8 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first soared by 2298.24% in 2018, then plummeted by 6919.32% in 2019.
  • Over the past 3 years, Medpace Holdings' Non-Current Debt (Quarter) stood at $79.7 million in 2018, then tumbled by 30.03% to $55.8 million in 2019, then surged by 347.64% to $249.7 million in 2022.
  • Its Non-Current Debt stands at $249.7 million for Q2 2022, versus $55.8 million for Q1 2019 and $79.7 million for Q4 2018.